SANFER Trademark

Trademark Overview


On Monday, March 23, 2020, a trademark application was filed for SANFER with the United States Patent and Trademark Office. The USPTO has given the SANFER trademark a serial number of 88843993. The federal status of this trademark filing is REGISTERED as of Tuesday, March 16, 2021. This trademark is owned by Laboratorios Sanfer, S.A. de C.V.. The SANFER trademark is filed in the Pharmaceutical Products category with the following description:

Medicines and pharmaceutical preparations, namely, pharmaceutical and medicinal products for ophthalmic use, antipyretics, analgesics, anesthetics, antiallergic medicines, antihistamines, antidotes, arsenic detoxification agents for medical purposes, benzol detoxification agents for medical purposes, chlorine detoxification agents for medical purposes, opium alkaloid preparations, smoking cessation preparations, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, anti-cancer preparations, anti-arthritic compositions and preparations, antiphlogistic analgesics, anti-rheumatic, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertensions, antitussives, expectorants, inhalant anesthetics, cardiovascular treatment preparations, analeptics, pharmaceutical preparations for treating hypertension, antibacterial pharmaceuticals, pharmaceutical preparations for the treatment of heart rhythm disorders, antihypertensives, vasodilators, chemot...
sanfer

General Information


Serial Number88843993
Word MarkSANFER
Filing DateMonday, March 23, 2020
Status700 - REGISTERED
Status DateTuesday, March 16, 2021
Registration Number6292319
Registration DateTuesday, March 16, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 29, 2020

Trademark Statements


Description of MarkThe mark consists of the word "SANFER" in stylized form.
Goods and ServicesMedicines and pharmaceutical preparations, namely, pharmaceutical and medicinal products for ophthalmic use, antipyretics, analgesics, anesthetics, antiallergic medicines, antihistamines, antidotes, arsenic detoxification agents for medical purposes, benzol detoxification agents for medical purposes, chlorine detoxification agents for medical purposes, opium alkaloid preparations, smoking cessation preparations, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, anti-cancer preparations, anti-arthritic compositions and preparations, antiphlogistic analgesics, anti-rheumatic, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertensions, antitussives, expectorants, inhalant anesthetics, cardiovascular treatment preparations, analeptics, pharmaceutical preparations for treating hypertension, antibacterial pharmaceuticals, pharmaceutical preparations for the treatment of heart rhythm disorders, antihypertensives, vasodilators, chemotherapeutics, antibiotic preparations, antifungal preparations, anti-tuberculous preparations, anti-leprotic agents, anti-protozoa preparations, medicinal preparations used in the treatment of malaria, antivirals, antiparasitic preparations, dermatological pharmaceutical products, antiparasitic preparations, dermatologics, radio-isotope markers for therapeutic or diagnostic use, dietary supplements, disinfectants, diuretics and anti-diuretics, antianemia drugs, anticoagulants, preparations for transfusions, enzymes for medical purposes, enzyme inhibitors, nutraceuticals for use as a dietary supplement for liver support, medicines for treatment of gastrointestinal diseases, antacids, diarrhea medication, anthelmintics, emetics, anti-emetic pharmaceutical preparations, medicated mouthwash for treating ulcers, antiflatulents, digestives for pharmaceutical purposes, medicines for use in indigestion, anti-inflammatories, laxatives, antiseptics, pharmaceutical preparations for the treatment and prevention of women's disorders and diseases, specifically, pharmaceutical preparations for assisted reproductive therapy, pharmaceutical preparations for the prevention and treatment of luteal phase defects and the prevention of miscarriages, immunosuppressants, dietary and nutritional supplements for anabolic use, antidiabetic preparations, dietary and nutritional supplements used for weight loss, pharmaceutical preparations for the treatment of anorexia; pharmaceutical agents affecting metabolism, pharmaceutical preparations for the treatment of Parkinson's disease, hypnotic sedatives, neuroleptics, tranquilizers, antidepressants, anti-psychotic pharmaceutical preparations, analeptics, neuropathical agents and other neurotropic agents, hormones for medical purposes, poly-opotherapeutic curative preparations for postponing manifestations of aging, estrogen preparations, progestogens, contraceptive preparations, androgen preparations, anti-hormone drugs, otorhinolaryngological preparations, otorhinolaryngological serums, vaccines, antispasmodics, vitamins, dietary and nutritional supplements containing coenzyme q10, multivitamin preparations, pharmaceutical preparations for sublingual use for treatment of heart problems; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 26, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLaboratorios Sanfer, S.A. de C.V.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCol. Tlacopac 01049
MX

Party NameLaboratorios Sanfer, S.A. de C.V.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCol. Tlacopac 01049
MX

Party NameLaboratorios Sanfer, S.A. de C.V.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCol. Tlacopac 01049
MX

Trademark Events


Event DateEvent Description
Monday, January 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 15, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, January 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 12, 2023WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, July 12, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, March 16, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, December 29, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 29, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 9, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 24, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, November 10, 2020ELECTRONIC RECORD REVIEW COMPLETE
Friday, October 30, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, October 27, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 26, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 26, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 26, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 15, 2020NON-FINAL ACTION E-MAILED
Wednesday, July 15, 2020NON-FINAL ACTION WRITTEN
Tuesday, June 23, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 22, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 22, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 18, 2020NON-FINAL ACTION E-MAILED
Thursday, June 18, 2020NON-FINAL ACTION WRITTEN
Monday, June 15, 2020ASSIGNED TO EXAMINER
Thursday, March 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 26, 2020NEW APPLICATION ENTERED